EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer

Léa Clusan, François Ferrière iD, Gilles Flouriot iD, Farzad Pakdel iD

International Journal of Molecular Sciences · 06.04.2023 · 24 (7) · 6834

DOI: 10.3390/ijms24076834 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.04.2023. Verfasst von Léa Clusan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Université de Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail)-UMR_S 1085, F-35000 Rennes, France. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 395-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MENRT scholarships from the French Minister of High Education, Research and Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is the most common cancer and the deadliest among women worldwide. Estrogen signaling is closely associated with hormone-dependent breast cancer (estrogen and progesterone receptor positive), which accounts for two-thirds of tumors. Hormone therapy using antiestrogens is the gold standard, but resistance to these treatments invariably occurs through various biological mechanisms, such as changes in estrogen receptor activity, mutations in the ESR1 gene, aberrant activation of the PI3K pathway or cell cycle dysregulations. All these factors have led to the development of new therapies, such as selective estrogen receptor degraders (SERDs), or combination therapies with cyclin-dependent kinases (CDK) 4/6 or PI3K inhibitors. Therefore, understanding the estrogen pathway is essential for the treatment and new drug development of hormone-dependent cancers. This mini-review summarizes current literature on the signalization, mechanisms of action and clinical implications of estrogen receptors in breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsFemaleHumansDrug Resistance, NeoplasmEstrogen AntagonistsEstrogensPhosphatidylinositol 3-KinasesReceptors, EstrogenSignal Transduction

Stichwörter der Autor:innen

breast cancerendocrine resistanceestrogen receptor

Substanzen

Estrogen AntagonistsEstrogensPhosphatidylinositol 3-KinasesReceptors, Estrogen

Autor:innen und Institutionen

  • Université de Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail)-UMR_S 1085, F-35000 Rennes, France.

ORCID-Profile: François Ferrière, Gilles Flouriot, Farzad Pakdel

Förderung

  • MENRT scholarships from the French Minister of High Education, Research and Innovation

Zitieren

APA

Clusan, L., Ferrière, F., Flouriot, G., & Pakdel, F. (2023). A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer. International Journal of Molecular Sciences, 24(7), 6834. https://doi.org/10.3390/ijms24076834

Vancouver

Clusan L, Ferrière F, Flouriot G, Pakdel F. A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer. International Journal of Molecular Sciences. 2023;24(7):6834. doi:10.3390/ijms24076834

BibTeX
@article{Clusan2023,
  author = {Clusan, Léa and Ferrière, François and Flouriot, Gilles and Pakdel, Farzad},
  title = {A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {7},
  pages = {6834},
  doi = {10.3390/ijms24076834}
}
Kostenlos starten →